World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 June 2016
Main ID:  NCT02804581
Date of registration: 15/06/2016
Prospective Registration: No
Primary sponsor: Lamis Kaddam
Public title: Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients
Scientific title: Potential Role of Gum Arabic as Immunomodulator In Sudanese Rheumatoid Arthritis Patients
Date of first enrolment: June 2016
Target sample size: 45
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02804581
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 2
Countries of recruitment
Sudan
Contacts
Name:     Alnour Elagib, MBBS,MRCP,MD
Address: 
Telephone: 00249912306262
Email: elagib62@hotmail.com
Affiliation: 
Name:     Amal M Saeed, MBBS,PhD
Address: 
Telephone:
Email:
Affiliation:  University of Khartoum
Name:     Ebtihal K Obied, MBBS
Address: 
Telephone: . 00249912279229
Email: E.Kamal.Ali@hotmail.com
Affiliation: 
Name:     Alnour Alagib, MBBS,MD,MRCP
Address: 
Telephone:
Email:
Affiliation:  Military hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Clinical diagnosis of Rheumatoid Arthritis

2. Clinically stable as evidenced by medical history, complete physical examination

3. All medications and dosages are stable for 6 weeks before study entry,

4. Non Pregnant ladies.

Exclusion Criteria:

- 1- hepatic, cardiovascular, pulmonary, malignant, hematologic, neurologic,
infectious, or inflammatory diseases unrelated to Rheumatoid arthritis.

2-Hospital admission within 4 weeks of start of the study.

3- Uncontrolled hypertension 4- Asthma or severe atopic disease;



Age minimum: 20 Years
Age maximum: 50 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Rheumatoid Arthritis
Intervention(s)
Dietary Supplement: Gum Arabic
Primary Outcome(s)
The level of C reactive protein (CRP)and Tumer necrosis factor alpha TNF [Time Frame: 12 weeks]
Secondary Outcome(s)
Total anti-oxidant capacity (TAC), malondialdehyde (MDA) and hydrogen peroxide (H2O2) level [Time Frame: 12 weeks]
clinical improvement [Time Frame: 12 weeks]
Secondary ID(s)
University of Khartoum
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Khartoum
Military hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history